The first vaccine is called Indovac for the state-owned enterprises (SOEs) vaccine, and the second one is the red and white vaccine, with an inactivated virus platform called Inavec
The vaccine offers lifetime protection.
The vaccine development will be based on serotypes found in Indonesia
The military, police, and local governments will encourage vaccination and conduct tracing more rigorously.
A decision to this effect was made during a limited cabinet meeting chaired by President Joko Widodo (Jokowi) at Merdeka Palace, Jakarta, on Monday.
"We provide free sterilization for 250 cats and rabies vaccine for 500 cats."
"Currently, we are doing clinical trials for the primary vaccine first. The possible priority is for the need for a booster (third dose) and for children. We still lack the supply of vaccines for children."
Vaccine distribution in the country declined quite sharply.
Convidecia vaccine is not yet included in the national vaccination program because the current supply is still deemed adequate.
The Ministry of Health reported that 40,967,039 people have received the third dose of the Covid-19 vaccine (booster) on Friday, May 6, 2022.
Ministry of Health has announced that Sinovac vaccine will be used as a COVID-19 booster shot.
PT Jakarta Biopharmaceuticals Industry (JBio) produces 1 million doses of Zifivax vaccine through technology transfer collaboration with Chinese pharmaceutical company Anhui Zhifei Longcom Biopharmaceutical.
Merah Putih Vaccine officially entered phase 2 clinical trials today to be tested on human research subjects to measure vaccine effectiveness, efficacy, and quality
Pre-existing condition shouldnt prevent the elderlies to get their COVID-19 vaccine doses even though they have to ensure the conditions are controlled.
Volunteers taking part in Merah Putih vaccine trial will be monitored for a year after they received the shot.
All subjects must be at least 18 years of age, and the phase one trial is planned to be carried out on February 9 at Regional Public Hospital (RSUD) Dr. Soetomo in Surabaya, East Java.
Minister of Health Budi Gunadi Sadikin also revealed that the majority of hospitalized patients who are in serious condition also havent received complete vaccine doses.
BPOM issues emergency use authorization (UEA) upon evaluation on the safety and efficacy aspects of Sinopharm vaccine, which will be used as homologous booster.
"I want people all over the world to be healthy. That way, I can retire. I can stop developing vaccines," he said.
Merah Putih vaccine has concluded its preclinical trial on animal and is currently awaiting phase one of clinical trial planned for early February.
